In vitro activity of telavancin and occurrence of vancomycin heteroresistance in isolates from patients enrolled in phase 3 clinical trials of hospital-acquired pneumonia

Authors:
  • JBJohanne Blais
    Johanne Blais
  • SLStacey R. Lewis
    Stacey R. Lewis
  • CLChristopher S. Lunde
    Christopher S. Lunde
  • SBSteven L. Barriere
    Steven L. Barriere
  • HFH. David Friedland
    H. David Friedland
  • MKMichael M. Kitt
    Michael M. Kitt
  • BBBret M. Benton
    Bret M. Benton

Abstract
No abstract available

This publication has 18 references indexed in Scilit: